Quantum-Si Inc. held its Investor & Analyst Day in New York City, where the company's management team provided updates on the development of the Proteus™ platform. Highlights included recent progress in platform development, a long-term technology roadmap aimed at achieving billions of reads, advancements toward coverage of all 20 amino acids, and new methods for detecting post-translational modifications. The company also shared data from over 50 sequencing runs on Proteus prototype systems, noting that performance already meets or exceeds that of the current Platinum® Pro system. Attendees were able to participate virtually by registering for the event.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quantum-Si Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251119647819) on November 19, 2025, and is solely responsible for the information contained therein.